Darwin Advisors, LLC Pfizer Inc Transaction History

Darwin Advisors, LLC

$197 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $20,364 - $26,511	-517 Reduced 9.08%	5,179 $211,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $7,181 - $9,374	-172 Reduced 2.93%	5,696 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $23,236 - $28,366	-531 Reduced 8.3%	5,868 $256,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $5,583 - $6,620	120 Added 1.91%	6,399 $318,000
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $10,568 - $13,095	-231 Reduced 3.55%	6,279 $325,000
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $11,610 - $17,211	-281 Reduced 4.14%	6,510 $352,000
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $184,789 - $237,377	-4,708 Reduced 40.94%	6,791 $292,000
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $10,880 - $12,326	303 Added 2.71%	11,499 $450,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $11,855 - $13,370	-354 Reduced 3.06%	11,196 $405,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $22,090 - $28,089	660 Added 6.06%	11,550 $425,000
Q3 2020 Oct 16, 2020	SELL	$31.75 - $37.25 $114,935 - $134,845	-3,620 Reduced 24.95%	10,890 $399,000
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $166,955 - $202,541	-5,543 Reduced 27.64%	14,510 $474,000
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $1.09 Million - $1.56 Million	-40,469 Reduced 66.87%	20,053 $654,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $84,011 - $95,342	2,552 Added 4.4%	60,522 $2.37 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $63,712 - $82,616	1,961 Added 3.5%	57,970 $2.08 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $34,946 - $39,236	945 Added 1.72%	56,009 $2.43 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $67,462 - $74,118	1,799 Added 3.38%	55,064 $2.34 Million
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $22,351 - $25,482	581 Added 1.1%	53,265 $2.32 Million
Q3 2018 Oct 23, 2018	BUY	$34.47 - $41.81 $255,181 - $309,519	7,403 Added 16.35%	52,684 $2.32 Million
Q2 2018 Aug 16, 2018	BUY	$32.98 - $35.16 $269,281 - $287,081	8,165 Added 22.0%	45,281 $1.65 Million
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $129,299 - $150,005	4,052 Added 12.26%	37,116 $1.32 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $220,048 - $233,478	6,616 Added 25.02%	33,064 $1.2 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $819,888 - $903,199	26,448	26,448 $944,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Account